SCHEMBL7944717

SCHEMBL7944717

COc1ccc(-c2ccc(CO)c(C)c2)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 1/20 0.43
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
FASN P49327 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
CDC7 O00311 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
GCGR P47871 1/20 0.40
PRKAB2 O43741 3/20 0.40
PRKAG1 P54619 3/20 0.40
PRKAA2 P54646 3/20 0.40
PRKAA1 Q13131 3/20 0.40
PRKAG3 Q9UGI9 3/20 0.40
PRKAG2 Q9UGJ0 3/20 0.40
PRKAB1 Q9Y478 3/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7946481 0.87 CYP11B1 (0.48) CYP11B1CYP11B2KDM4EALDH1A1PDCD1
SCHEMBL8024217 0.86 PDCD1 (0.56) CYP11B1CYP11B2KDM4EALDH1A1PDCD1
SCHEMBL7946478 0.84 CYP1A1 (0.55) CYP11B1CYP11B2PDCD1CD274SMN1; SMN2
SCHEMBL15719330 0.80 FFAR1 (0.48) CYP11B1CYP11B2PDCD1CD274
SCHEMBL3994452 0.80 RAB9A (0.47) CYP11B1CYP11B2KDM4EPDCD1CD274
SCHEMBL8007347 0.80 AKR1C3 (0.47) CYP11B1CYP11B2PDCD1CD274SMN1; SMN2
SCHEMBL3127408 0.79 ALDH1A1 (0.47) CYP11B1CYP11B2KDM4EALDH1A1MEN1
SCHEMBL7945286 0.79 PDCD1 (0.43) CYP11B1CYP11B2KDM4EALDH1A1PDCD1
SCHEMBL5753110 0.78 ALDH1A1 (0.54) CYP11B1CYP11B2KDM4EALDH1A1MEN1
SCHEMBL2549337 0.77 CYP2A6 (0.47) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010015653-A1 PYRIMIDINE DERIVATIVES AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE SMITHKLINE BEECHAM CORPORATION (US) 2010-02-11 WO disclosed
WO-2009071504-A1 2,6-DISUBSTITUTED PYRIDINES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO disclosed